Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Gland Pharma Limited Call Transcript 2023

Aug 7, 2023

59319_rns_2023-08-07_6008827e-4c15-48c0-a812-3af7c18d5ca3.pdf

Call Transcript

Open in viewer

Opens in your device viewer

==> picture [59 x 48] intentionally omitted <==

==> picture [298 x 20] intentionally omitted <==

August 07, 2023

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers 25[th] floor, Dalal Street Mumbai - 400 001 Scrip Code: 543245

National Stock Exchange of India Limited Listing Department Exchange Plaza, 5th floor Plot no. C-1, Block G, Bandra Kurla Complex Bandra (East), Mumbai - 400 051 Symbol: GLAND (ISIN: INE068V01023)

Dear Sir/Madam,

Sub: Earnings Call Recording

Pursuant to Regulations 30 and 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; please note that the Earnings Call for the quarter ended June 30,2023, was held on August 07, 2023 at 19:30 Hrs. (IST) and the audio recording of the call has been uploaded on our website.

The weblink to access the same is https://glandpharma.com/images/GNP0220230807148477.mp3

This is for your information and records.

Yours truly, For Gland Pharma Limited

KUMAR Digitally signed by KUMAR PALLERLAMUDI SAMPATH PALLERLAMUDI DN: cn=KUMAR PALLERLAMUDI SAMPATH, c=IN, o=Personal, email=[email protected] SAMPATH Date: 2023.08.07 22:56:35 +05'30'

P Sampath Kumar

Company Secretary and Compliance Officer

==> picture [596 x 78] intentionally omitted <==